Pharma companies improve manufacturing, ensure quality: Ramadoss

New Delhi, Dec 18 (UNI) Health Minister Anbumani Ramadoss today said Indian pharma companies would improve the manufacturing and analysis of drugs and pharamaceuticals to the international level without compromising their quality by following the pharmacopoeial standards.

Releasing the Indian Pharmacopoea 2007, Dr Ramadoss said the publication has been considerably revised and improved by introducing advanced technology and experimental methods widely adopted in India and abroad.

He said the Indian Pharmacopoeia is published in fulfilment of the requirements in accordance with the Drugs and Cosmetic Rules, 1945 for the standards of drugs manufactured and marketed in India.

The standards given in this pharmacopoeia are authoritative, legally enforceable and intended to help in the inspection and licensing of manufacturing and distribution of drugs and pharmaceuticals.

The Indian Pharmacopoeia 2007 is the 5th edition subsequent to Indian Pharmacopoeia 1996 and its Addenda 2000, 2002, 2005 and the Veterinary Products Supplement in 2002.

There had been rapid changes in the standards of drug and pharmaceuticals all over the world. To keep pace with the regulatory requirements, and in the wake of formation of Indian Pharmacopoeia Commission, there was demand by all stakeholders for taking out the new edition of the Indian Pharmacopoeia.

More UNI